Back to top

Mindray (MR) Enters Oversold Territory
March 10, 2014

Read MoreHide Full Article
Mindray Medical International Ltd’s share price has entered into oversold territory with an RSI value of 28.7. The Zacks Consensus Estimate for Mindray for the full year period has improved 2 cents over the past two months to $2.14 per share. Currently, Mindray has a Zacks Rank #2 (Buy), suggesting that now might be a good time to get in on after its recent drop.



Normally $25 each - click below to receive one report FREE:



More from Zacks Tale of the Tape

You May Like